Delepine N, Delepine G, Cornille H, Voisin M C, Brun B, Desbois J C
Department of Paediatric Oncology University-Robert Debré Hospital, Paris, France.
J Chemother. 1997 Oct;9(5):352-63. doi: 10.1179/joc.1997.9.5.352.
To bring to the fore the most important prognostic factors in Ewing's sarcoma (ES) with current protocols, we studied the classical prognostic factors, dose intensity (DI) of actual received drugs, age and histological response to induction therapy and their correlation in 39 patients with localized ES treated from 11/85 to 06/95 to identify eventual predictors of event-free survival (EFS). Inclusion criteria were age 35 yr or less, definitive local treatment by our team and chemotherapy including at least 4 drugs: vincristine (VCR), dactinomycin (DACT), doxorubicin (DOXO) cyclophosphamide (CPX). The endpoint was the absence of relapse. Parameters related to the status of patients were tested using the Chi square test or Fisher's exact test. The non parametric Kruskal-Wallis test was used for quantitative data. When necessary stratified analysis was done using the Mantel Cox test. With a median follow-up of 7 yr, overall survival (OS) and EFS were both 67% at 7 yr. According to univariate analysis, the significant predictors of survival were the DI of VCR and DACT, the histological response to preoperative chemotherapy (CT), the patient's age (< 18 yr DFS: 84%; > 18 yr DFS: 38%). The risk of metastases was almost tenfold higher in patients with low received DI of VCR (DFS 40% versus 95%) and of DACT (DFS 48% versus 94%). The prognostic value of primary tumor characteristics (tumoral volume or location) was erased by the comprehensive treatment. Following multivariate analysis, the actual received DI of VCR (p < 0.02) and DACT (p < 0.03) and the histological response to preoperative CT (p < 0.05) were retained as the only significant independent predictors of EFS. Taking into account the actual received DI of VCR and DACT, the prognostic value of age disappears. In conclusion, this study points out the main role of the drug DI in ES (particularly VCR and DACT) and of histological response to preoperative CT.
为了通过当前方案找出尤因肉瘤(ES)最重要的预后因素,我们研究了经典预后因素、实际接受药物的剂量强度(DI)、年龄以及诱导治疗的组织学反应,并对1985年11月至1995年6月期间接受治疗的39例局限性ES患者进行了这些因素及其相关性的研究,以确定无事件生存(EFS)的最终预测因素。纳入标准为年龄35岁及以下、由我们团队进行确定性局部治疗以及化疗,化疗至少包括4种药物:长春新碱(VCR)、放线菌素D(DACT)、阿霉素(DOXO)、环磷酰胺(CPX)。终点为无复发。使用卡方检验或费舍尔精确检验对与患者状态相关的参数进行检验。定量数据使用非参数Kruskal-Wallis检验。必要时使用Mantel Cox检验进行分层分析。中位随访7年时,7年总生存(OS)率和EFS率均为67%。单因素分析显示,生存的显著预测因素为VCR和DACT的DI、术前化疗(CT)的组织学反应、患者年龄(<18岁DFS:84%;>18岁DFS:38%)。接受VCR的DI较低的患者(DFS 40%对95%)和接受DACT的DI较低的患者(DFS 48%对94%)发生转移的风险几乎高出10倍。综合治疗消除了原发肿瘤特征(肿瘤体积或位置)的预后价值。多因素分析后,实际接受的VCR(p<0.02)和DACT(p<0.03)的DI以及术前CT的组织学反应(p<0.05)被保留为EFS的唯一显著独立预测因素。考虑到实际接受的VCR和DACT的DI,年龄的预后价值消失。总之,本研究指出了药物DI在ES(特别是VCR和DACT)以及术前CT的组织学反应中的主要作用。